Repertaxin
CAS No. 266359-83-5
Repertaxin ( Repertaxin; DF 1681Y )
Catalog No. M17461 CAS No. 266359-83-5
Reparixin is a potent inhibitor of both CXCL8 receptorsCXCR1/2, it inhibits weaklyCXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocksCXCR1-mediated chemotaxis (IC50=1 nM).
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 65 | In Stock |
|
5MG | 110 | In Stock |
|
10MG | 177 | In Stock |
|
25MG | 372 | In Stock |
|
50MG | 556 | In Stock |
|
100MG | 791 | In Stock |
|
500MG | 1575 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRepertaxin
-
NoteResearch use only, not for human use.
-
Brief DescriptionReparixin is a potent inhibitor of both CXCL8 receptorsCXCR1/2, it inhibits weaklyCXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocksCXCR1-mediated chemotaxis (IC50=1 nM).
-
DescriptionReparixin is a potent inhibitor of both CXCL8 receptorsCXCR1/2, it inhibits weaklyCXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocksCXCR1-mediated chemotaxis (IC50=1 nM).
-
SynonymsRepertaxin; DF 1681Y
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCXCR1; CXCR2
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number266359-83-5
-
Formula Weight283.39
-
Molecular FormulaC14H21NO3S
-
Purity98%
-
SolubilityDMSO : ≥ 500 mg/mL; 1764.35 mM
-
SMILESCS(=O)(=O)NC(=O)[C@@H](c1ccc(CC(C)C)cc1)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moriconi A, et al. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2. J Med Chem. 2007 Aug 23;50(17):3984-4002.
molnova catalog
related products
-
OMDM-5
OMDM-5 is a potent vanilloid receptor type 1 (TRPV1, EC50 = 75 nM) agonist, showing weak ligand activity at cannabinoid type 1 receptor (CB1, Ki=4.9 μM).
-
SMM-295
A novel potent, selective cannabinoid receptor 2 (CB2) agonist with Ki of 12 nM.
-
Hemopressin (human, ...
Bioactive endogenous peptide substrate for endopeptidase 24.15 (ep24.15), neurolysin (ep24.16) and ACE. Ki values are 27.76, 3.43 and 1.87 μM respectively. Potent hypotensive in vivo. Also acts as a selective CB1 receptor inverse agonist. Displays antinociceptive activity in vivo.